ArticleClinical, cosmetic and investigational dermatology2025
Efficacy and Safety Evaluation of 595 nm Pulsed Dye Laser Treatment in 120 Cases of Asian Infants With Port Wine Stain.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to evaluate the efficacy and safety of a 595 nm pulsed dye laser (PDL) for the treatment of port wine stain (PWS) in 120 Asian infant patients. Methods: A retrospective analysis was carried out to assess the efficacy and safety of 595 nm PDL in 120 Asian infant patients with PWS. Results: This study identified excellent (21.67%), good (23.33%), fair (30.83%), and poor (15.83%) clearance. Multiple treatments significantly improved efficacy, with 61.56% of patients achieving good or excellent responses after more than six sessions. Younger patients showed better treatment outcomes than older patients did. The lesion location influenced the response, with leg lesions exhibiting the poorest response. The pink lesions were the most susceptible, whereas the purple lesions displayed the least response. Smaller lesions (<10 cm²) showed a size-dependent excellent rate (41.0%) and lower poor rate (5.1%). Conclusion: The 595 nm PDL treatment displayed a favorable safety profile, with only mild, well-tolerated adverse effects. Rare adverse effects were resolved within 3-6 months. No severe adverse events were reported. The 595 nm PDL is safe and effective for Asian infant patients with PWS. The side effects were mild and well-tolerated by the patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.